Citations

Citations to this article as recorded by  

• External validation of a deep learning-based algorithm for detection of tall cells in papillary thyroid carcinoma: A multicenter study
  Sebastian Stenman, Sylvain Bétrisey, Paula Vainio, Jutta Huvila, Mikael Lundin, Nina Linder, Anja Schmitt, Aurel Perren, Matthias S. Dettmer, Caj Haglund, Johanna Arola, Johan Lundin
  Journal of Pathology Informatics.2024; 15: 100366.     CrossRef
• Focal Tall Cell Change in Papillary Thyroid Carcinoma: Lessons Learned from Practices Adopting Rigid Criteria (Height to Width Ratio of 3)
  Esther Diana Rossi, Liron Pantanowitz
  Endocrine Pathology.2024; 35(1): 80.     CrossRef
• Papillary Thyroid Carcinomas with Tall Cell Features: An Intermediate Entity Between Classic and Tall Cell Subtypes
  Athanasios Bikas, Kristine Wong, Theodora Pappa, Sara Ahmadi, Craig B. Wakefield, Ellen Marqusee, Pingping Xiang, Benjamin Altshuler, Jacob Haase, Justine A. Barletta, Iñigo Landa, Erik K. Alexander
  Thyroid.2023; 33(6): 697.     CrossRef
• A novel nomogram for identifying high-risk patients among active surveillance candidates with papillary thyroid microcarcinoma
  Li Zhang, Peisong Wang, Kaixuan Li, Shuai Xue
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• The Impact of BRAF V600E Mutation Allele Frequency on the Histopathological Characteristics of Thyroid Cancer
  Mawaddah Abdulhaleem, Saruchi Bandargal, Marc Philippe Pusztaszeri, Mohannad Rajab, Hannah Greenspoon, Joshua Ross Krasner, Sabrina Daniela Da Silva, Véronique-Isabelle Forest, Richard J. Payne
  Cancers.2023; 16(1): 113.     CrossRef
• Protruding Huge Thyroid Mass Concurrent Hemorrhage and Skin Necrosis: A Case Report
  Solji An, Joonseon Park, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim
  Journal of Endocrine Surgery.2023; 23(4): 143.     CrossRef
• CD56 Expression in Papillary Thyroid Carcinoma Is Highly Dependent on the Histologic Subtype: A Potential Diagnostic Pitfall
  Uiju Cho, Yourha Kim, Sora Jeon, Chan Kwon Jung
  Applied Immunohistochemistry & Molecular Morphology.2022; 30(5): 389.     CrossRef
• Aggressive histopathological variants of papillary thyroid carcinoma, diagnostic challenge, and clinical significance—A case series
  PK Pravanya, KR Anila, Shaji Thomas, A Sreekumar, K Jayasree
  Medical Journal of Dr. D.Y. Patil Vidyapeeth.2022;[Epub]     CrossRef
• Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis
  Shabnam Samankan, Leah Militello, Gabriella Seo, Sedef Everest, Quinn O'Malley, Sarah L. Spaulding, Monica Xing, Ammar Matloob, John Beute, Raymond Chai, Scott Doyle, Mark L. Urken, Margaret Brandwein-Weber
  Pathology - Research and Practice.2022; 236: 154012.     CrossRef
• A population-based study of the three major variants of papillary thyroid carcinoma
  Junming Xu, Yingying Zhang, Jun Liu, Shenglong Qiu, Min Wang
  Journal of International Medical Research.2021; 49(2): 030006052098461.     CrossRef
• Tall cell percentage alone in PTC without aggressive features should not guide patients’ clinical management
  Anello Marcello Poma, David Viola, Elisabetta Macerola, Agnese Proietti, Eleonora Molinaro, Dario De Vietro, Rossella Elisei, Gabriele Materazzi, Paolo Miccoli, Fulvio Basolo, Clara Ugolini
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(10): e4109.     CrossRef
• Molecular Pathology of Non-familial Follicular Epithelial–Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification
  Paula Soares, Antónia Afonso Póvoa, Miguel Melo, João Vinagre, Valdemar Máximo, Catarina Eloy, José Manuel Cameselle-Teijeiro, Manuel Sobrinho-Simões
  Endocrine Pathology.2021; 32(1): 44.     CrossRef
• Deep Neck Infection: Atypical Presentation of Papillary Thyroid Cancer
  Apichana Mahattanapreut, Rangsima Aroonroch, Chalermchai Chintrakarn, Chutintorn Sriphrapradang, Dinesh K. Chhetri
  Case Reports in Otolaryngology.2021; 2021: 1.     CrossRef
• The evolving concept of aggressive histological variants of differentiated thyroid cancer
  Juan C. Hernandez-Prera
  Seminars in Diagnostic Pathology.2020; 37(5): 228.     CrossRef
• Papillary Thyroid Cancer—Aggressive Variants and Impact on Management: A Narrative Review
  Andrés Coca-Pelaz, Jatin P. Shah, Juan C. Hernandez-Prera, Ronald A. Ghossein, Juan P. Rodrigo, Dana M. Hartl, Kerry D. Olsen, Ashok R. Shaha, Mark Zafereo, Carlos Suarez, Iain J. Nixon, Gregory W. Randolph, Antti A. Mäkitie, Luiz P. Kowalski, Vincent Van
  Advances in Therapy.2020; 37(7): 3112.     CrossRef
• Contemporary evaluation and management of tall cell variant of papillary thyroid carcinoma
  Sara Cartwright, Abbey Fingeret
  Current Opinion in Endocrinology, Diabetes & Obesity.2020; 27(5): 351.     CrossRef
• Le carcinome papillaire de la thyroïde avec contingent à cellules hautes : facteurs pronostiques
  I. Riahi, H. Jaafoura, H. Saibi, E. Chebil, I. Ben Nacef, M. Ksentini, T. Ben Ghachem, R. Lahiani, M. Ben Salah
  Annales d'Endocrinologie.2020; 81(4): 345.     CrossRef
• Updates in the Pathologic Classification of Thyroid Neoplasms: A Review of the World Health Organization Classification
  Yanhua Bai, Kennichi Kakudo, Chan Kwon Jung
  Endocrinology and Metabolism.2020; 35(4): 696.     CrossRef
• Tall Cell Variant of Papillary Thyroid Carcinoma: Impact of Change in WHO Definition and Molecular Analysis
  Kristine S. Wong, Sara E. Higgins, Ellen Marqusee, Matthew A. Nehs, Trevor Angell, Justine A. Barletta
  Endocrine Pathology.2019; 30(1): 43.     CrossRef
• Histopatological and molecular genetic characteristics of clinically aggressive variants of papillary thyroid carcinoma
  A. V. Bogolyubova, A. Yu. Abrosimov, L. S. Selivanova, P. V. Belousov
  Arkhiv patologii.2019; 81(1): 46.     CrossRef
• Papillary Thyroid Cancers with Focal Tall Cell Change are as Aggressive as Tall Cell Variants and Should Not be Considered as Low-Risk Disease
  Pim J. Bongers, Wouter P. Kluijfhout, Raoul Verzijl, Mattan Lustgarten, Marloes Vermeer, David P. Goldstein, Karen Devon, Lorne E. Rotstein, Sylvia L. Asa, James D. Brierley, Richard W. Tsang, Shereen Ezzat, Menno R. Vriens, Ozgur Mete, Jesse D. Pasternak
  Annals of Surgical Oncology.2019; 26(8): 2533.     CrossRef
• A case-based approach to aggressive variants of papillary thyroid carcinoma with literature review
  JosephAntoine Flordelis Chatto, AnnetteLaurente Salillas
  Thyroid Research and Practice.2019; 16(3): 128.     CrossRef
• Clinically Relevant Prognostic Parameters in Differentiated Thyroid Carcinoma
  Tyler Janovitz, Justine A. Barletta
  Endocrine Pathology.2018; 29(4): 357.     CrossRef
• Prediction of novel target genes and pathways involved in tall cell variant papillary thyroid carcinoma
  Fada Xia, Bo Jiang, Yong Chen, Xin Du, Yao Peng, Wenlong Wang, Zhuolu Wang, Xinying Li
  Medicine.2018; 97(51): e13802.     CrossRef
• Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis
  Huy Gia Vuong, Nguyen Phuoc Long, Nguyen Hoang Anh, Tran Diem Nghi, Mai Van Hieu, Le Phi Hung, Tadao Nakazawa, Ryohei Katoh, Tetsuo Kondo
  Endocrine Connections.2018; 7(12): R286.     CrossRef
• TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma
  Eun Ji Oh, Sohee Lee, Ja Seong Bae, Yourha Kim, Sora Jeon, Chan Kwon Jung
  Endocrine Pathology.2017; 28(1): 49.     CrossRef
• Update on the cytologic features of papillary thyroid carcinoma variants
  Marc Pusztaszeri, Manon Auger
  Diagnostic Cytopathology.2017; 45(8): 714.     CrossRef
• Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive f
  Uiju Cho, Ozgur Mete, Min-Hee Kim, Ja Seong Bae, Chan Kwon Jung
  Modern Pathology.2017; 30(6): 810.     CrossRef
• BRAF-positive paucicellular variant of anaplastic carcinoma in the presence of tall cell variant papillary thyroid cancer
  O. V. Dolzhansky, E. M. Paltseva, D. N. Khmelkova, F. A. Konovalov, I. V. Kanivets, A. V. Lavrov, D. V. Pyankov, S. A. Korostelev, O. A. Levendyuk, V. M. Pominalnaya, D. N. Fedorov
  Arkhiv patologii.2017; 79(3): 27.     CrossRef
• A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis
  Zeming Liu, Wen Zeng, Tianwen Chen, Yawen Guo, Chao Zhang, Chunping Liu, Tao Huang
  Oncotarget.2017; 8(4): 6222.     CrossRef
• Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation
  Ja Seong Bae, Yourha Kim, Sora Jeon, Se Hee Kim, Tae Jung Kim, Sohee Lee, Min-Hee Kim, Dong Jun Lim, Youn Soo Lee, Chan Kwon Jung
  Diagnostic Pathology.2016;[Epub]     CrossRef
• Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biology
  Xiaofei Wang, Wenli Cheng, Chongqing Liu, Jingdong Li
  Oncotarget.2016; 7(26): 40792.     CrossRef
• The Warthin-Like Variant of Papillary Thyroid Carcinoma: A Comparison with Classic Type in the Patients with Coexisting Hashimoto’s Thyroiditis
  Min-kyung Yeo, Ja Seong Bae, Sohee Lee, Min-Hee Kim, Dong-Jun Lim, Youn Soo Lee, Chan Kwon Jung
  International Journal of Endocrinology.2015; 2015: 1.     CrossRef
• BRAF Immunohistochemistry Using Clone VE1 is Strongly Concordant with BRAFV600E Mutation Test in Papillary Thyroid Carcinoma
  Jung-Soo Pyo, Jin Hee Sohn, Guhyun Kang
  Endocrine Pathology.2015; 26(3): 211.     CrossRef
• Pathologie de la thyroïde. Cas no 3. Carcinome papillaire de la thyroïde, variante à cellules hautes
  Emmanuelle Leteurtre
  Annales de Pathologie.2015; 35(5): 402.     CrossRef